DEXRABEPRAZOLE SODIUM Enteric-coated tablet Ref.[51201] Active ingredients: Dexrabeprazole

Source: Web Search  Publisher: Stallion laboratories Pvt. Ltd., C-1B, 305/2,3,4 & 5, GIDC, Kerala (Bavla) Dist: Ahmedabad-382220, Gujarat, India

4.1. Therapeutic indications

DEXRABEPRAZOLE SODIUM TABLETS indicated for Gastro esophageal reflux disease, gastric and duodenal ulcers.

4.2. Posology and method of administration

DEXRABEPRAZOLE SODIUM TABLETS are depending upon the clinical requirements in individual cases, the following daily doses are recommended:

Adults: 10 mg once daily for 4-8 weeks depending upon condition and response.

Maintenance: 5-10 mg once daily.

4.9. Overdose

Any medication taken in excess can have serious consequences. If you suspect an overdose of Dexrabeprazole Sodium, seek medical attention immediately.

6.3. Shelf life

24 months for the date of manufacturing.

6.4. Special precautions for storage

Store below 30ยบC. Protect from light. Keep out of reach of children.

6.5. Nature and contents of container

2x14 Tablets in Alu PVC blister pack.

6.6. Special precautions for disposal and other handling

There are no special storage precautions. Any unused product or waste material should be disposed of in accordance with local requirements.

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.